Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2006 1
2007 1
2008 4
2009 2
2010 7
2011 2
2012 3
2013 14
2014 17
2015 16
2016 18
2017 26
2018 35
2019 29
2020 25
2021 50
2022 54
2023 31
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Results by year

Filters applied: . Clear all
Page 1
Retrospective evaluation of a TEN/SJS series managed with a new treatment protocol.
Steinhoff M, Buddenkotte J, Al-Shafi W, Al-Marri H, Emam F, Iqneibi M, Harris TRE, Thomas SH, Asad SM, Al-Maslamani H, Joy FE, Therachiyil L, Jochebeth A, Leo R, Younis SM, Abu Raddad LJ, Dargham SR, Al-Khawaga S. Steinhoff M, et al. J Eur Acad Dermatol Venereol. 2024 May 7. doi: 10.1111/jdv.20060. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38713099 No abstract available.
Leveraging wastewater surveillance for managing the spread of SARS-CoV-2 and concerned pathogens during FIFA World Cup Qatar 2022.
El-Malah SS, Saththasivam J, K AK, Abdul Jabbar K, Gomez TA, Wahib S, Lawler J, Tang P, Mirza F, Al-Hail H, Ouararhni K, Abdul Azis TK, Abu Raddad LJ, Chemaitelly HS, Abu Halaweh HA, Khalife S, Bertollini R, Mahmoud KA. El-Malah SS, et al. Heliyon. 2024 Apr 26;10(9):e30267. doi: 10.1016/j.heliyon.2024.e30267. eCollection 2024 May 15. Heliyon. 2024. PMID: 38711666 Free PMC article.
Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination.
Younes S, Nicolai E, Pieri M, Bernardini S, Daas HI, Al-Sadeq DW, Younes N, Shurrab FM, Nizamuddin PB, Humaira F, Al-Dewik N, Yassine HM, Abu-Raddad LJ, Ismail A, Nasrallah GK. Younes S, et al. Among authors: abu raddad lj. Influenza Other Respir Viruses. 2024 May;18(5):e13290. doi: 10.1111/irv.13290. Influenza Other Respir Viruses. 2024. PMID: 38706402 Free PMC article.
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
Sukik L, Chemaitelly H, Ayoub HH, Coyle P, Tang P, Yassine HM, Al Thani AA, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abdel-Rahman ME, Abu-Raddad LJ. Sukik L, et al. Among authors: abu raddad lj. Vaccine. 2024 Apr 13:S0264-410X(24)00440-7. doi: 10.1016/j.vaccine.2024.04.026. Online ahead of print. Vaccine. 2024. PMID: 38616439 Free article.
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant.
Chemaitelly H, Coyle P, Kacem MAB, Ayoub HH, Tang P, Hasan MR, Yassine HM, Al Thani AA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Among authors: abu raddad lj. J Travel Med. 2024 Apr 9:taae053. doi: 10.1093/jtm/taae053. Online ahead of print. J Travel Med. 2024. PMID: 38591115
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.
Chemaitelly H, Ayoub HH, Tang P, Yassine HM, Al Thani AA, Hasan MR, Coyle P, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Among authors: abu raddad lj. Front Med (Lausanne). 2024 Mar 11;11:1363045. doi: 10.3389/fmed.2024.1363045. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38529118 Free PMC article.
SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
Zedan HT, Smatti MK, Al-Sadeq DW, Al Khatib HA, Nicolai E, Pieri M, Bernardini S, Hssain AA, Taleb S, Qotba H, Issa K, Abu Raddad LJ, Althani AA, Nasrallah GK, Yassine HM. Zedan HT, et al. Among authors: abu raddad lj. J Med Virol. 2024 Mar;96(3):e29527. doi: 10.1002/jmv.29527. J Med Virol. 2024. PMID: 38511514
322 results